Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb/IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 342.00 | |
5 mg | In stock | $ 828.00 | |
10 mg | In stock | $ 1,150.00 | |
25 mg | In stock | $ 1,680.00 | |
50 mg | In stock | $ 2,290.00 |
Description | Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb/IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes. |
In vivo | Lefradafiban (30, 45, and 60 mg; oral; three times daily for 48 hours; patients with stable angina undergoing angioplasty) is an effective oral glycoprotein IIb/IIIa receptor blocker.[1] |
Synonyms | BIBU 104, BIBU104, BIBU-104 |
Molecular Weight | 439.46 |
Formula | C23H25N3O6 |
CAS No. | 149503-79-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (102.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lefradafiban 149503-79-7 Others BIBU 104 BIBU104 BIBU-104 inhibitor inhibit